SCHEMBL250406

SCHEMBL250406

CN(N=O)C([NH])=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1044593 0.73 ALDH1A1 (0.44)
SCHEMBL11306264 0.73 ALDH1A1 (0.44)
SCHEMBL103330 0.71
N-Methyl-N-Nitrosurea SCHEMBL28025247 0.69 ALDH1A1 (0.39)
N-Methyl-N-Nitrosurea SCHEMBL38377 0.69
SCHEMBL8427528 0.69
SCHEMBL3500103 0.69
SCHEMBL22895 0.68
SCHEMBL128211 0.67
N-Methyl-N-Nitrosurea SCHEMBL28057965 0.67 ALDH1A1 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-3940383-A ANTICANCER STANFORD RESEARCH INSTITUTE (US) 1976-02-24 US claimed
US-20240239764-A1 SUBSTITUTED AMINOBENZYL HETEROARYL COMPOUNDS AS EGFR AND/OR PI3K INHIBITORS THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2024-07-18 US disclosed
US-20240150452-A1 MULTIFUNCTIONAL PROTEIN MOLECULES COMPRISING DECORIN AND USE THEREOF CATALENT PHARMA SOLUTIONS, LLC 2024-05-09 US disclosed
US-20240083868-A1 SUBSTITUTED AMINOBENZYL HETEROARYL COMPOUNDS AS EGFR AND/OR PI3K INHIBITORS MEKANISTIC THERAPEUTICS, LLC 2024-03-14 US disclosed
US-20240050415-A1 DACLATASVIR FOR USE IN TREATING LUNG AND PROSTATE CANCER HENRY FORD HEALTH SYSTEM (US) 2024-02-15 US disclosed
US-11879009-B2 Multifunctional protein molecules comprising decorin and use thereof CATALENT PHARMA SOLUTIONS, LLC (US) 2024-01-23 US disclosed
US-11746151-B2 Compositions and methods for treating cancer THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2023-09-05 US disclosed
US-11673876-B2 Substituted aminobenzyl heteroaryl compounds as EGFR and/or PI3K inhibitors MEKANISTIC THERAPEUTICS LLC (US) 2023-06-13 US disclosed
US-20220213054-A1 SUBSTITUTED AMINOBENZYL HETEROARYL COMPOUNDS AS EGFR AND/OR PI3K INHIBITORS MEKANISTIC THERAPEUTICS LLC (US) 2022-07-07 US disclosed
US-11377488-B2 Multifunctional protein molecules comprising decorin and use thereof CATALENT PHARMA SOLUTIONS, LLC (US) 2022-07-05 US disclosed
US-20090010878-A1 Pulsatile dosing of gossypol for treatment of disease ASCENTA THERAPEUTICS, INC. (US) 2009-01-08 US disclosed
US-20080253997-A1 COMPOSITIONS AND METHODS FOR PROTECTING CELLS FROM TOXIC EXPOSURES PERSCITUS BIOSCIENCES, LLC (US) 2008-10-16 US disclosed
US-20080125430-A1 NEW SMALL MOLECULE INHIBITORS OF MDM2 AND THE USES THEREOF THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2008-05-29 US disclosed
US-20080095755-A1 Methods and compositions for the treatment of cancer QUINTESSENCE BIOSCIENCES, INC. (US) 2008-04-24 US disclosed
US-20080021095-A1 Small Molecule Antagonists of Xiap Family Proteins THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2008-01-24 US disclosed
US-20060247318-A1 Small molecule inhibitors of STAT3 and the uses thereof NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2006-11-02 US disclosed
US-20060211757-A1 INHIBITORS OF MURINE DOUBLE MINUTE-2(MDM2) SUCH AS (2'R,3'S,4'R,5'R)6-CHLORO-4'-2,2-DIMETHYL-PROPYL-2'-(2,2-DIMETHYL-PROPYL)-2-OXO-1,2-DIHYDRO-SPIRO[INDOLE-3,3'-PYRROLIDINE]-5'-CARBOXYLIC ACID(3-MORPHOLIN-4-YL-PROPYL)-AMIDE, USED FOR INDUCING APOPTOSIS AND CELL CYCLE ARREST; ANTIPROLIFERATIVE AGENTS REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2006-09-21 US disclosed
US-20050261232-A1 Non-natural ribonuclease conjugates as cytotoxic agents QUINTESSENCE BIOSCIENCES, INC. (US) 2005-11-24 US disclosed
US-20050058725-A1 Combination therapy including a matrix metalloproteinase inhibitor and an antineoplastic agent MCKEARN JOHN P (US) 2005-03-17 US disclosed
US-3940383-A ANTICANCER STANFORD RESEARCH INSTITUTE (US) 1976-02-24 US disclosed